Please assess the completion status of the following clinical trial:

Trial Title: Model 20105 Lead Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has Cardiac pacing indication for sinus node dysfunction (dual chamber pacemaker)~* Subject has signed and dated the study-specific informed consent form~* Subject is 18 years of age or older~* Subject is willing, able and committed to participate in Baseline and Follow-up and study procedures for the full length of the study~Exclusion Criteria:~* Subject is indicated for BiV pacemaker or ICD~* Subject is pacing dependent~* Subject has a previous Pacemaker System~* Subject has known coronary venous vasculature that is inadequate for lead placement~* Subject has unstable angina pectoris or has had an acute myocardial infarction (MI) within the last month~* Subject has had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past three months~* Subject is not in sinus rhythm at implant~* Subject has had a heart transplant (patients waiting for heart transplants are allowed in the study)~* Subject has known renal insufficiency that would prevent them from receiving an occlusive venogram during the implant procedure~* Subject is contraindicated for \<1mg dexamethasone acetate~* Subject is enrolled in any concurrent drug and/or device study that may confound the results of this study~* Subject has a terminal illness and is not expected to survive more than 6 months~* Subject is a pregnant woman or woman of childbearing potential not on adequate birth control.~* Subject is employed by Medtronic or by the department of any of the investigators or is a close relative of any of the investigators.~* Legal incapacity or evidence that a subject cannot understand the purpose and risks of the study~* Subject meets exclusion criteria required by local law.~* Subject is unable to tolerate an urgent thoracotomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Model 20105 (Type: EXPERIMENTAL): Receiving the model 20105 Lead

Based on this trial design, predict the completion outcome and termination type (if applicable).